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Low systemic vascular resistance:
differential diagnosis and outcome
Jairo Melo and Jay I Peters
Objective: To determine the frequency and prognosis of the various causes of
low systemic vascular resistance (SVR).
Design: Analysis of consecutive patients over a 5-year period; retrospective
review.
Setting: Medical intensive care unit of a large university hospital.
Patients: Fifty-five patients with unexplained hypotension and a SVR less than
800 dynes × s/cm5.
Background: There are minimal data in the medical literature determining the
frequency or outcome of patients with a low SVR that is unrelated to sepsis or
the sepsis syndrome. We retrospectively reviewed and analyzed all
hemodynamic data in a large university hospital over a 5-year period to determine
the frequency and prognosis of the various causes of low SVR. Fifty-five patients
with unexplained hypotension and a SVR less than 800 dynes × s/cm5 were
identified.
Main results: Twenty-two patients (Groups 1 and 2) met the criteria for sepsis
syndrome. The mean SVR for this group was 445 ± 168 dynes × s/cm5 with an
associated mortality of 50%. Group 3 contained 20 patients with possible
sepsis. Thirteen patients (Group 4) were nonseptic. The mean SVR of this group
was 435 ± 180 dynes × s/cm5 with an associated mortality of 46%. Extremely low
SVR (below 450 dynes × s/cm5) was associated with a significantly higher
mortality regardless of the etiology.
Conclusions: At least a quarter of patients with hypotension and a low SVR
have nonseptic etiologies. The patients with nonseptic etiologies have a similar
mortality to septic patients. Clinicians should be aware of the wide spectrum of
conditions that induce a low SVR.
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Introduction
As initially described by Poiseuille’s law, resistance to
flow is that resistance provided by a vessel or circulatory
bed which permits a given pressure differential to
produce a unit flow. Transcribed to human hemodynam-
ics, systemic vascular resistance (SVR) can be measured
from the differential pressure between the mean arterial
pressure (MAP) and the central venous pressure (CVP)
divided by the flow, ie cardiac output (CO). Although
many clinical conditions can cause a low SVR, septic
shock remains the most common cause and usually results
in a severe decrease in SVR. In more than 90% of patients
with septic shock who are aggressively volume loaded, the
CO is initially normal or elevated. Therefore, hypotension
results from reduced vascular resistance with normal or
elevated CO. This form of shock results from maldistribu-
tion of blood flow to tissues, usually from acute vasodilata-
tion without concomitant expansion of the intravascular
volume. While distributive shock can also be caused by
anaphylaxis, drug ingestion, neurogenic injury, and
adrenal insufficiency, these conditions are seen with less
frequency in the intensive care unit. Therefore, a hemo-
SVR = systemic vascular resistance; MAP = mean arterial pressure; CVP = central venous pressure; CO = cardiac output; CI = cardiac index;
SVRI = systemic vascular resistance index; WBC = white blood count; EHS = extreme hyperdynamic state; TNF = tumor necrosis factor; IL =
interleukin; ACTH = adrenocorticotrophic hormone; ATP = adenosine triphosphate.
dynamic state with low SVR is often considered synony-
mous of sepsis, and other conditions associated with a low
SVR may not be considered.
There are minimal data in the medical literature assessing
the frequency or outcome of patients with distributive
shock that is unrelated to sepsis or the sepsis syndrome.
Since we could find no prior studies in the literature
assessing the etiology and outcome of hypotensive
patients with a low SVR, we reviewed our experience with
patients undergoing hemodynamic monitoring in the
medical intensive care unit of a large university hospital.
The purpose of this study was to determine the different
causes of low SVR, identify prognostic factors, and analyze
the mortality of these various groups of patients.
Methods
After approval by the Institutional Review Board of the
University of Texas Health Science Center at San
Antonio, medical records of all patients admitted to the
medical intensive care unit of the University Hospital
between 1990–1995 were reviewed. All the charts of
patients undergoing pulmonary artery catheterization
were identified. Patients with a recorded SVR less than
800dynes×s/cm5 were analyzed. The main indication for
pulmonary artery catheterization in patients in this study
was unexplained hypotension after volume challenge. Any
patient with an unclear etiology for hypotension or any
patient requiring more than 10µg/kg/min dopamine
underwent pulmonary artery catheterization and was
reviewed for this study. Anxiolytics, sedatives, and neuro-
muscular blocking agents are administered by protocol
and have minimal or no direct effects on hemodynamics or
histamine release. Cultures of blood and urine were
obtained on all patients; cultures of sputum, pleural fluid,
ascitic fluid, and cerebrospinal fluid were obtained as clin-
ically indicated. Toxicological screening of blood and
urine for drugs was performed on admission if the etiology
of hypotension was in question. Serum cortisol level deter-
mination was performed on all patients receiving exoge-
nous corticosteroids or in patients with known risk factors
for adrenal insufficiency. Hematologic and blood chem-
istry determinations, arterial blood gases, routine urinaly-
sis, and serial electrocardiograms were obtained on all
patients.
Mean systemic, right atrial, and pulmonary artery pres-
sures and thermodilution cardiac outputs were measured
every 4h in all patients. Derived hemodynamic variables
were calculated as follows: cardiac index (CI; l/min/m2) =
CO/body surface area; SVR (dynes×s/cm5)= (80×
MAP)/CO; and systemic vascular resistance index
(SVRI)=SVR/body surface area. Patients received vaso-
pressors to maintain MAP above 70mmHg. The set of
hemodynamic data with the lowest SVR was selected for
each patient.
All historical, clinical, laboratory, microbiologic, and hemo-
dynamic data were studied. Patients were divided into
four groups based on the following parameters: (1) positive
blood culture; (2) temperature ≥38.1°C or ≤36°C; (3)
white blood counts (WBCs) ≥12000/mm3 or ≤4000/mm3;
and (4) obvious source of infection. Group 1 (definite
sepsis) had positive blood cultures and two or more crite-
ria; Group 2 (probable sepsis) had an obvious source of
infection and two or more additional criteria; Group 3
(possible sepsis) had fever and leukocytosis or leukopenia
with no obvious source of infection nor positive blood
culture; and Group 4 (nonseptic) had none of the criteria.
The clinical course, laboratory findings, hemodynamics,
and intensive care unit mortality were compared between
the various groups. Data are expressed as mean ± standard
deviation. Clinical and hemodynamic variables were com-
pared with a student’s t-test and by analysis of variance to
assess statistical significance between groups. Logistic
regression analysis was performed comparing SVR and
death using a univariant analysis.
Mortality was assessed by Mann-Whitney rank sum test. A
P value of ≤0.05 was considered statistically significant.
Results
Fifty-five patients were included in the study (Table 1).
Group 1 contained 18 patients with definite sepsis; Group 2
contained four patients with probable sepsis; Group 3
contained 20 patients with possible sepsis; and Group 4 con-
tained 13 patients who had no evidence of sepsis. The mean
age of the patients was 50±13.6years. Thirty-four patients
were men, and 21 patients were women. The overall MAP
was 72±20mmHg at the moment the hemodynamic values
were chosen. The overall mean CO was 9.2±6.18l/min, and
the mean CI was 5.1±1.7l/min/m2. The overall mean SVR
was 435±180dynes×s/cm5; the mean SVRI was
785±325dynes×s/cm5. Analysis of SVRI was reviewed for
each subgroup and not found to be different from the analy-
sis of SVR; therefore, only data for SVR are presented.
There were no statistically significant differences in age,
sex, or admission temperature among the different groups.
Twenty-two patients (Groups 1 and 2) met the criteria for
the sepsis syndrome [1]. The mean SVR was
445±168dynes×s/cm5, CO was 10.86±5.22 l/min; and CI
was 5.08±1.64 l/min/m2 for this group. The overall mortal-
ity in those patients classified as having the sepsis syn-
drome was 50%. In patients with the sepsis syndrome, the
lung was the primary site of infection in 14 out of 22
patients. Thirteen patients were considered nonseptic
(Group 4). This group had no source of infection, alter-
ation in temperature, leukocytosis, or leukopenia. The
mean hemodynamic values for this group were:
SVR=435±180dynes×s/cm5; CO = 9.23±4.24 l/min, and
CI=7.72±1.9 l/min/m2. The mortality was 46%. There
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were no statistically significant differences in any hemody-
namic values nor in mortality between the nonseptic
group (Group 4) and the groups with sepsis syndrome
(Groups 1 and 2). The nonseptic group included eight
patients with intra-abdominal disease (five with decom-
pensated cirrhosis, three with acute pancreatitis), one
patient with adrenal insufficiency, and four patients with
unclear etiologies for hypotension and low SVR (idio-
pathic). The mortality in patients with decompensated
intra-abdominal disease was 75% (six out of eight). Addi-
tionally, no statistically significant difference in any of the
hemodynamic values or mortality was identified between
the four groups when analyzed individually (Table 2).
Twenty-seven patients met the criteria for the extreme
hyperdynamic state (EHS). In the literature [2], EHS is
defined as an SVR below 450 dynes×s/cm5 and a CO
above 7 l/min/m2. The mean hemodynamic values for
patients in this study with EHS were: SVR=
327±85dynes×s/cm5; CO=12.13±3.31 l/min; and CI=
5.98±1.46 l/min/m2. Seven of these patients had a diagno-
sis of underlying cirrhosis. Twelve of the patients within
this group were diagnosed with sepsis syndrome, 10 with
possible sepsis, and five were nonseptic. This group had a
statistically significant higher mortality (60% versus 33%)
than those patient without the EHS (P<0.05). A univari-
ant logistic regression was performed analyzing the level
of reduction of SVR and mortality. A statistically signifi-
cant relationship was found between these variables
(P=0.025). For every reduction in SVR of 50dynes×
s/cm5, there was a 20% increase in mortality (odds ratio=
1.2; range=1.022–1.434).
Discussion
Sepsis and sepsis syndrome were the most common etiolo-
gies of a low SVR in this study. Although many studies
have found urinary or intra-abdominal sepsis to be the
most common cause of low SVR [3], the lung was the
primary site of infection in over half of our patients.
Septic shock, the leading cause of intensive care unit mor-
tality, is caused by systemic activation of the inflammatory
cascade. Numerous mediators, including cytokines,
kinins, complement, coagulation factors, and eicosanoids,
are activated or systematically released, resulting in pro-
found disturbances of cardiovascular and organ system
function. These mediators, particularly tumor necrosis
factor (TNF), interleukin (IL)-1, platelet activating factor,
and prostaglandins, are thought to mediate the reduced
peripheral vascular resistance seen in septic shock [4–6].
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Table 1
Clinical parameters of study groups
Agea Temperatureb
Group Number (mean ± SD) (mean ± SD) Clinical diagnoses
Group 1: definitive sepsis 18 52 ± 12 101.5 ± 1.6°F Pneumonia (10); urinary tract infection (3); abdominal 
sepsis (2); toxic shock syndrome (1); meningitis (1); 
cellulitis (1)
Group 2: probable sepsis 4 48 ± 10 99.3 ± 4.17°F Pneumonia (4)
Group 3: possible sepsis 20 51 ± 12.5 100.3 ± 2.36°F Spontaneous bacterial peritonitis (5); idiopathic (3)
Group 4: nonseptic 13 44 ± 17 98.4 ± 1.8°F Cirrhosis (5); idiopathic (4); pancreatitis (3); adrenal 
insufficiency (1)
aP > 0.05; bP < 0.01, between Group 1 + 2 versus Group 4
Table 2
Mean hemodynamic values and mortality ( ± SD)a
Group Number MAP CO CI SVR Mortality
Group 1: definitive sepsis 18 67.6 ± 22.7 10.19 ± 3.3 5.23 ± 1.5 455 ± 144 8/18 (44%)
Group 2: probable sepsis 4 50.0 ± 27.6 9.83 ± 3.6 4.38 ± 1.9 506 ± 123 3/4 (75%)
Group 3: possible sepsis 20 71.4 ± 15 9.70 ± 3.0 5.37 ± 1.6 483 ± 167 12/20 (60%)
Group 4: nonseptic 13 74.7 ± 29 9.23 ± 4.2 4.72 ± 1.9 507 ± 222 6/13 (46%)
Combined data 55 71.7 ± 20.8 9.76 ± 0.36 5.10 ± 1.7 435 ± 180 29/55 (53%)
MAP, mean arterial pressure (mmHg); CO, cardiac output (l/min); CI,
cardiac index (l/min/m2); SVR, systemic vascular resistance 
(dynes × s/cm5). aP > 0.05 for comparisons for hemodynamics and
mortality between groups.
Parker et al [7] studied serial cardiovascular variables in
humans with septic shock. A low SVR was seen in both
survivors and nonsurvivors; however, persistently low SVR
beyond 24 h was a strong predictor of mortality. This study
demonstrated that the majority of patients (65%) who die
of septic shock have a persistently low SVR, while a
smaller percentage die of low CO (10%) or of multiple
organ failure (25%) after hemodynamic resolution of
shock. Although we did not evaluate serial hemodynamic
profiles in this study, our data identify a group of patients
with EHS who demonstrate a SVR below 450dynes×
s/cm5 and a mean CO over 12 l/min. As with patients in
prior studies [2], this group demonstrated a significantly
higher mortality. Although the mechanisms relating to the
difference in mortality are unknown, it has been sug-
gested that patients with “complicated” shock (defined as
multiorgan failure) have greater distortions of cardiorespi-
ratory patterns relative to the degree of hypotension and
that this is associated with a higher mortality [8,9]
Our study demonstrates that patients with sepsis syn-
drome are the most common group of patients presenting
with hypotension and a low SVR in the medical intensive
care unit. This group only represents approximately 40%
of patients in our study. While many of the remaining
patients had some evidence supporting the diagnosis of
sepsis (eg fever, leukocytosis), they lacked an identifiable
source of infection, and the exact etiology of their
hypotension remains unknown. More significantly, almost
one-quarter of the patients (24%) in this study developed
hypotension and a low SVR without any evidence of
sepsis. This group had a high mortality (46%), similar to
the remaining patients (54%). There were no significant
differences in the clinical or hemodynamic parameters
between the nonseptic patients and the patients in the
remaining groups. The frequency of nonseptic causes of a
low SVR suggest that clinicians must be aware of condi-
tions other than sepsis that have either been well docu-
mented (Table 3) or reported to induce a reduction in the
SVR (Table 4).
The largest group of nonseptic patients in this study with
hypotension and a low SVR was found to be patients with
decompensated cirrhosis. Although occult infections
should not be excluded, none of these patients had fever,
leukocytosis, an identifiable site of infection, or abnormal-
ities in the peritoneal fluid. Patients with liver cirrhosis
often present with systemic hemodynamic disturbances,
including hypotension, low SVR, and a reduced sensitivity
to vasoconstrictors [10]. The precise mechanisms of these
hemodynamic disorders have not yet been clearly eluci-
dated. Excessive production of vasodilators, peripheral
shunts, and increased levels of nitric oxide in these
patients may contribute to the hyperdynamic state
observed in this population [10–16]. A recent study by
Matsumoto [16] demonstrated that patients with decom-
pensated liver cirrhosis had higher levels of exhaled nitric
oxide than patients with compensated cirrhosis, chronic
liver disease, or controls. The decompensated cirrhotics
had a significantly higher CO and a lower SVR than the
compensated patients. Additionally, a positive correlation
was found between the level of nitric oxide and CI. Five
of our patients with a low SVR had decompensated liver
disease as the presumed etiology of their hypotension.
Another five patients in the possible sepsis group had
hypotension with a clinical diagnosis of spontaneous bac-
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Table 3
Documented conditions associated with low SVR
Condition Comment
Sepsis Most common cause of low SVR
Pancreatitis Seen with necrotizing or hemorrhagic 
pancreatitis
Cirrhosis Seen with decompensated liver disease
Adrenal insufficiency Only 15 well documented cases
Head injury Seen after initial rise in SVR
Beriberi Rapid response to thiamine
Salicylate (chronic) Seen in elderly patients, illness mimics sepsis
TMP-SMX Reported only in AIDS patients
Vasoplegic syndrome Occurs within 6 h postcardiopulmonary 
bypass
Incidence estimated to be 0.4%–5.0%
SVR, systemic vascular resistance (dynes × s/cm5); TMP-SMX,
trimethoprim-sulfamethoxazole. See text for discussion.
Table 4
Conditions reported to have low SVR
Condition Comment
Anaphylaxis Conflicting hemodynamic data; low SVR after 
fluid repletion
Myocardial infarction Rare, minimal evidence in humans
Ovarian Hyperadrenergic and hypermetabolic state
hyperstimulation 
syndrome/burns
Thyrotoxicosis Animal studies only
Multiple myeloma Three documented cases
Anemia Hemoglobin < 7 g; results not reproducible
Hyperthermia Few well-documented cases
Tricyclic Little hemodynamic data available
antidepressants
Paget’s disease Arterovenous shunts
Spinal cord injury Injury above T6; inhibited vagal tone
SVR, systemic vascular resistance in dynes × s/cm5
terial peritonitis; however, the lack of positive cultures, or
any other evidence of infection, suggest that decompen-
sated liver disease may have played a significant role in
their hypotension.
Pancreatitis was found to be the second most common
cause of low SVR in patients without evidence of infection.
Three patients had necrotizing pancreatitis, with one of
these having evidence of hemorrhage into the pancreas.
Hemodynamic manifestations of pancreatitis include a nor-
modynamic or hypodynamic state, usually present in acute
interstitial pancreatitis and commonly associated with hypo-
volemia. Pancreatitis can also present as a hyperdynamic
state with high CO and a low SVR as described by Di Carlo
et al [17] and Bradley et al [18]. This hyperdynamic state is
another manifestation of the severity of acute pancreatitis
and is seen mostly in necrotizing pancreatitis with or
without hemorrhage [19]. Severe pancreatitis may mimic
sepsis syndrome or septic shock despite the absence of any
infectious site. The mechanisms responsible for pancreatic
shock have not been elucidated; however, an inflammatory
cascade generalized by cytokines and TNF is felt to be the
most likely cause of this process [17–19].
Adrenal insufficiency was found in one of our patients with
no evidence of infection. Unfortunately, cortisol levels and
adrenocorticotrophic hormone (ACTH) response was not
routinely measured in patients with infection, and adrenal
insufficiency may have been underestimated in this group.
Adrenal insufficiency may present as a hypodynamic, nor-
modynamic, or hyperdynamic state [20]. The hypodynamic
state is usually seen early in adrenal insufficiency and is
associated with volume depletion from diarrhea, vomiting,
and decreased reabsorption of sodium in the distal tubule.
CO may also be decreased in adrenal insufficiency as the
result of the myofibrillar adenosine triphosphate (ATP)
depletion seen with glucocorticoid deficiency [20]. Intra-
venous fluid therapy most often increases CO and
decreases SVR in patients with adrenal crisis. These
patients are usually separated from patients with sepsis by
a baseline cortisol level below 10µg/dl or an inadequate
response to ACTH [20]. One of our patients with septic
shock had baseline cortisol of 22µg/dl and no response to
the cosyntropin stimulation test. This patient could not be
weaned off high dose norepinephrine and dopamine until
intravenous corticosteroids were instituted. Normal values
for basal and stimulated cortisol levels are derived from the
adrenal response of healthy individuals. Patients experi-
encing the severe stress of critical illness demonstrate
higher than normal amounts of circulating cortisol. Some
patients with critical illness have minimal or no ACTH
stimulation above their baseline cortisol levels and may be
unable to respond to additional physiologic stress [20].
Several reports suggest a significant number of critically ill
patients may have unrecognized adrenal insufficiency
[21–24].
Four cases of idiopathic hypotension with low SVR were
identified in our patients. One case was felt to be related
to possible anaphylaxis or anaphylactoid reaction but was
not well documented. Silverman et al [25] reported a
patient who developed anaphylactic shock secondary to
penicillin 7 days postmyocardial infarction; the hemody-
namic parameters showed a decrease in CO and MAP with
an increase in SVR. Moss et al [26] reported the opposite
hemodynamic profile in a patient with anaphylactic shock
secondary to succinycholine. Their patient developed a
low SVR and a high CO which correlated with increased
levels of histamine and catecholamines. Although there
are minimal human data, animal studies suggest there is
an initial hypodynamic state secondary to severe extrava-
sation of fluids into the tissues followed by a hyper-
dynamic state after fluid resuscitation.
Our second case of hypotension with a low SVR presented
in the setting of an acute myocardial infarction. Although
cardiogenic shock presents with a high SVR and low CO,
some data suggest that, rarely, patients may present with a
syndrome of low SVR. McCriskin et al [27] reported a
patient with a left ventricular pseudoaneurysm post-
myocardial infarct with a low SVR and no evidence of
infection. Costantin [28] developed an animal model in
dogs and demonstrated a subset of animals with a hyper-
dynamic state after coronary occlusion; however, Ross et al
[29] were unable to confirm these results using another
animal model. Similarly, Smith et al [30], in one of the
original hemodynamic descriptions of patients after
myocardial infarction, did not identify any patient with a
hyperdynamic state. Another recently described cause of
low SVR in cardiac patients is the “vasoplegic syndrome”.
This syndrome occurs within 6 h after cardiac surgery
using extracorporeal circulation [31]. The incidence has
been estimated between 0.4 and 5% of patients undergo-
ing cardiovascular surgery using cardiopulmonary bypass
[31,32]. The etiology is unclear but has not been associ-
ated with increased levels of nitric oxide or endotoxin.
One patient with a low SVR classified as idiopathic had a
history of significant alcohol consumption. Their initial
hemodynamic parameters showed a low SVR with high
CO which rapidly resolved after intravenous thiamine and
broad-spectrum antibiotics. It is possible that this case
represents a variant of beriberi heart disease. This rare but
treatable disease should be considered in every patient
with congestive heart failure and a low SVR. The fulmi-
nant form known as Shosin beriberi presents as a high CO
state with extremely high CO and a low SVR which
rapidly responds to thiamine [33–35].
The remaining patient in the idiopathic group had no
explanation for their low SVR syndrome. Review of the
literature shows many causes of a low SVR (Tables 3 and
4), and it is possible that one of these diagnosis was missed
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by the clinicians caring for this patient. The patient had
normal urine drug abuse screens and a normal serum
acetaminophen level. A salicylate level was not obtained.
Leatherman and Schmitz [36] reported a series of five
patients who became accidentally intoxicated with salicy-
lates with clinical, laboratory, and hemodynamic features
of sepsis, but without bacteriological evidence. In two of
the cases, TNF-α, IL-1 and IL-6 were measured and
found to be significantly elevated. Other drugs have been
associated with a low SVR including tricyclic antidepres-
sants, anesthetic agents, and narcotics. Recently Nguyen
et al [37] reported hyperdynamic shock caused by
trimethoprim-sulfamethoxazole in which immunoglobulin
E antibodies and TNF were not detected and comple-
ment levels were normal, suggesting a mechanism other
than anaphylaxis. Our drug screen should have identified
tricyclic antidepressants or narcotics in the urine; however,
a careful drug history was not elicited in this patient.
Although other conditions such as head injury [38–40],
Paget’s disease [41–43], arteriovenous fistula [44], severe
anemia [45,46], multiple myeloma [47], thyrotoxicosis
[48], and spinal cord injury [49] have been reported to
produce a low SVR, this patient lacked any clinical evi-
dence suggesting one of these diagnoses; his hypotension
resolved spontaneously.
Conclusion
In summary, we describe a group of 55 patients with a
SVR below 800dynes×s/cm5, and a subgroup of 13 non-
septic patents (24%) with a similar mortality. This study
emphasizes the importance of considering other condi-
tions besides sepsis in patients presenting with hypoten-
sion and a low SVR.
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